![Latest COVID-19 vaccine based on technology tested for safety & immunogenicity in IMI Ebola projects | IMI Innovative Medicines Initiative Latest COVID-19 vaccine based on technology tested for safety & immunogenicity in IMI Ebola projects | IMI Innovative Medicines Initiative](https://www.imi.europa.eu/sites/default/files/styles/newsroom_details/public/uploads/images/news-events/Newsroom/j%20and%20j%20by%20rafapress%20via%20shutterstock.jpg?itok=gZGJMJG9)
Latest COVID-19 vaccine based on technology tested for safety & immunogenicity in IMI Ebola projects | IMI Innovative Medicines Initiative
![SSPH+ | Attitudes Toward COVID-19 Vaccination Among Young Adults in Zurich, Switzerland, September 2020 SSPH+ | Attitudes Toward COVID-19 Vaccination Among Young Adults in Zurich, Switzerland, September 2020](https://www.ssph-journal.org/files/Articles/643486/ijph-66-643486-HTML-r1/image_m/ijph-66-643486-g001.jpg)
SSPH+ | Attitudes Toward COVID-19 Vaccination Among Young Adults in Zurich, Switzerland, September 2020
![Europe OKs Johnson & Johnson's COVID-19 vaccine, but deliveries won't start till April | FiercePharma Europe OKs Johnson & Johnson's COVID-19 vaccine, but deliveries won't start till April | FiercePharma](https://qtxasset.com/fiercepharma/1615493147/jnjleiden.jpg/jnjleiden.jpg?VersionId=D.u_wJvKUkgqJH_JEkf0kOtC1nDyvgq)
Europe OKs Johnson & Johnson's COVID-19 vaccine, but deliveries won't start till April | FiercePharma
![Europe won't renew AstraZeneca, Johnson & Johnson COVID-19 vaccine contracts next year: report | FiercePharma Europe won't renew AstraZeneca, Johnson & Johnson COVID-19 vaccine contracts next year: report | FiercePharma](https://qtxasset.com/fiercepharma/1618407369/GettyImages-1218961180.jpg/GettyImages-1218961180.jpg?VersionId=MCixIJBERZTVp0dR_oDnCRsDmaIbydzd)